{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:17:56Z","timestamp":1783948676774,"version":"3.55.0"},"reference-count":9,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,6,11]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>Systemic mastocytosis results from proliferation and activation of an abnormal mast cell clone. It is a heterogeneous disorder with clinical manifestations ranging from skin lesions alone to aggressive multi-organ infiltration and decreased survival. Given these varied manifestations, diagnosis can be difficult. We describe the case of a woman who presented with rash and diarrhoea and had a history of anaphylactic reactions. Over a protracted period, the patient\u2019s symptoms were investigated by a number of specialties including gastroenterology, dermatology, immunology and haematology. Morphological, immunohistochemical and molecular analysis of bone marrow samples ultimately led to a diagnosis of systemic mastocytosis. Management with leukotriene and histamine antagonists resulted in significant improvement in symptoms and quality of life. The case serves to highlight the protean manifestations of systemic mastocytosis, the tests available to diagnose it and the agents available to treat it.<\/jats:p>","DOI":"10.1136\/bcr-2019-229967","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T08:29:32Z","timestamp":1567153772000},"page":"e229967","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Systemic mastocytosis: variable manifestations can lead to a challenging diagnostic process"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-601X","authenticated-orcid":false,"given":"Susanna","family":"Nallamilli","sequence":"first","affiliation":[{"name":"Haematology, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aideen","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Haematology, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wilson","sequence":"additional","affiliation":[{"name":"Haematology, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallika","family":"Sekhar","sequence":"additional","affiliation":[{"name":"Haematology, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lambert","sequence":"additional","affiliation":[{"name":"Haematology, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"2025082702341436000_12.8.e229967.1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12916"},{"key":"2025082702341436000_12.8.e229967.2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2109"},{"key":"2025082702341436000_12.8.e229967.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1409760"},{"key":"2025082702341436000_12.8.e229967.4","unstructured":"Swerdlow SH , Campo E , Harris NL , et al , eds. World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2016."},{"key":"2025082702341436000_12.8.e229967.5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.iac.2018.04.002","article-title":"Nonclonal mast cell activation syndrome: a growing body of evidence","volume":"38","author":"Hamilton","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"2025082702341436000_12.8.e229967.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781278"},{"key":"2025082702341436000_12.8.e229967.7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(16)31403-9","article-title":"Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study","volume":"389","author":"Lortholary","year":"2017","journal-title":"Lancet"},{"key":"2025082702341436000_12.8.e229967.8","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s10067-016-3368-9","article-title":"Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review","volume":"35","author":"Latar","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025082702341436000_12.8.e229967.9","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1097\/01.pas.0000213310.51553.d7","article-title":"Systemic mastocytosis mimicking inflammatory bowel disease: a case report and discussion of gastrointestinal pathology in systemic mastocytosis","volume":"30","author":"Bedeir","year":"2006","journal-title":"Am J Surg Pathol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-229967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:34:22Z","timestamp":1756287262000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-229967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":9,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,30]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bcr-2019-229967"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-229967","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}